 | Up a level |
Chan, Jia Jia and Zhang, Bin and Chew, Xiao Hong and Salhi, Adil and Kwok, Zhi Hao and Lim, Chun You and Desi, Ng and Subramaniam, Nagavidya and Siemens, Angela and Kinanti, Tyas and Ong, Shane and Sanchez-Mejias, Avencia and Ly, Phuong Thao and An, Omer and Sundar, Raghav and Fan, Xiaonan and Wang, Shi and Siew, Bei En and Lee, Kuok Chung and Chong, Choon Seng and Lieske, Bettina and Cheong, Wai-Kit and Goh, Yufen and Fam, Wee Nih and Ooi, Melissa G. and Koh, Bryan T. H. and Iyer, Shridhar Ganpathi and Ling, Wen Huan and Chen, Jianbin and Yoong, Boon-Koon and Chanwat, Rawisak and Bonney, Glenn Kunnath and Goh, Brian K. P. and Zhai, Weiwei and Fullwood, Melissa J. and Wang, Wilson and Tan, Ker-Kan and Chng, Wee Joo and Dan, Yock Young and Pitt, Jason J. and Roca, Xavier and Guccione, Ernesto and Vardy, Leah A. and Chen, Leilei and Gao, Xin and Chow, Pierce K. H. and Yang, Henry and Tay, Yvonne (2022) Pan-cancer pervasive upregulation of 3 ` UTR splicing drives tumourigenesis. Nature Cell Biology, 24 (6). 928+. ISSN 1465-7392, DOI https://doi.org/10.1038/s41556-022-00913-z.
Ang, Yvonne L. E. and Ho, Gwo Fuang and Soo, Ross A. and Sundar, Raghav and Tan, Sing Huang and Yong, Wei Peng and Ow, Samuel G. W. and Lim, Joline S. J. and Chong, Wan Qin and Soe, Phyu Pyar and Tai, Choo and Wang, Lingzhi and Goh, Boon Cher and Lee, Soo-Chin (2020) A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC Cancer, 20 (1). ISSN 1471-2407, DOI https://doi.org/10.1186/s12885-020-07616-4.
